"We thank our stockholders for their support through our time as a public company and the duration of this process,” said Nick Green, president and CEO of Avid Bioservices. "We look forward to ...

Researchers at Durham University have achieved a major advancement in understanding how proteins bind metals inside cells, a process crucial to life. The study, published in Nature Communications, ...

Lumi is available for early-stage process development. Reach Industries hopes to eventually offer the system for use in GMP compliancy.

From a margin perspective, Danaher's operations should eventually improve once top-line growth rebounds. With that operating leverage-related margin expansion, we expect Danaher's adjusted EPS to grow ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

A Winnipeg-based biotechnology company says it's open to any financial help it can get from Ottawa as the U.S. continues to ...

CRANBURY, NEW JERSEY / ACCESS Newswire / January 28, 2025 / AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process de ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Costly biomanufacturing sterilization process are impeding food-tech companies from scaling up — a problem Biosphere is ...